Top

International Journal of Colorectal Disease

Published in:

01-10-2008 | Original Article

Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF)

Authors: Julia Brenmoehl, Werner Falk, Michael Göke, Jürgen Schölmerich, Gerhard Rogler

Published in: International Journal of Colorectal Disease | Issue 10/2008

Abstract

Background

Migration of colonic lamina propria fibroblasts (CLPF) plays an important role during mucosal wound healing as well as fibrosis and fistula formation in Crohn’s disease (CD). Recently, we showed that the migratory potential of CD-CLPF was significantly reduced compared to control CLPF. Fistula-derived CD-CLPF migrated less and fibrosis-CLPF more than CLPF from inflamed CD mucosa. These changes in migratory behavior were associated with changes in production of the migration-inducing fibronectin (FN) isoforms ED-A and ED-B. A permanent reduction of the migratory potential of CLPF was mediated by IFN-γ and tumor necrosis factor (TNF) modulate FN isofom expression in CLPF and thereby might regulate CLPF migration.

Materials and methods

Control CLPF were incubated for 72 h with IFN-γ, TNF, IFN-γ plus TNF, or TGF-β1. Messenger RNA (mRNA) was isolated and expression of FN and isoforms ED-A and ED-B was quantified by real-time polymerase chain reaction. FN, ED-A, and ED-B were investigated by Western blotting. FN receptor integrin α5β1 was analyzed by FACS.

Results

No difference was found for the surface display of integrin α5β1 between stimulated and non-stimulated cells. In TGF-β1 incubated CLPF mRNA amount of FN and isoforms ED-A and ED-B was slightly increased. IFN-γ only decreased FN in CLPF, TNF significantly reduced FN-mRNA by 40%, FN ED-A mRNA by 25%, and ED-B mRNA by 50%. The TNF-mediated mRNA downregulation resulted in a decreased protein amount as revealed by Western blotting.

Conclusion

Cytokines such as IFN-γ, TNF, and TGF-β1 modulate the production of fibronectin isoforms. Our data indicate that inflammation-induced modulation of FN-isoform production is involved in the alterations of migratory potential of CLPF isolated from CD mucosa.

Hynes RO (1990) Fibronectins. Springer series in molecular biology. Springer, New York

Hynes RO (1985) Fibronectins: a family of complex and versatile adhesive glycoproteins derived from a single gene. Harvey Lect 81:133–152PubMed

Zardi L, Carnemolla B, Siri A, Petersen TE, Paolella G, Sebastio G, Baralle FE (1987) Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J 6:2337–2342PubMed

Vartio T, Laitinen L, Narvanen O, Cutolo M, Thornell LE, Zardi L, Virtanen I (1987) Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 88(Pt 4):419–430PubMed

Schwarzbauer JE (1991) Fibronectin: from gene to protein. Curr Opin Cell Biol 3:786–791PubMedCrossRef

Owens RJ, Kornblihtt AR, Baralle FE (1986) Fibronectin, the generation of multiple polypeptides from a single gene. Oxf Surv Eukaryot Genes 3:141–160PubMed

Hynes R (1985) Molecular biology of fibronectin. Annu Rev Cell Biol 1:67–90PubMedCrossRef

Kornblihtt AR, Umezawa K, Vibe-Pedersen K, Baralle FE (1985) Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J 4:1755–1759PubMed

Schwarzbauer JE, Tamkun JW, Lemischka IR, Hynes RO (1983) Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 35:421–431PubMedCrossRef

10.

Sekiguchi K, Klos AM, Kurachi K, Yoshitake S, Hakomori S (1986) Human liver fibronectin complementary DNAs: identification of two different messenger RNAs possibly encoding the alpha and beta subunits of plasma fibronectin. Biochemistry 25:4936–4941PubMedCrossRef

11.

Ffrench-Constant C, Van De Water L, Dvorak HF, Hynes RO (1989) Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109:903–914PubMedCrossRef

12.

Barnes JL, Hastings RR, De la Garza MA (1994) Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol 145:585–597PubMed

13.

Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM (1994) Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 127:2037–2048PubMedCrossRef

14.

Kuhn C III, Boldt J, King TE Jr., Crouch E, Vartio T, McDonald JA (1989) An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 140:1693–1703PubMed

15.

Coito AJ, Brown LF, Peters JH, Kupiec-Weglinski JW, Van De WL (1997) Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts. Am J Pathol 150:1757–1772PubMed

16.

Dubin D, Peters JH, Brown LF, Logan B, Kent KC, Berse B, Berven S, Cercek B, Sharifi BG, Pratt RE (1995) Balloon catheterization induced arterial expression of embryonic fibronectins. Arterioscler Thromb Vasc Biol 15:1958–1967PubMed

17.

Takasaki I, Chobanian AV, Mamuya WS, Brecher P (1992) Hypertension induces alternatively spliced forms of fibronectin in rat aorta. Hypertension 20:20–25PubMed

18.

Castellani P, Viale G, Dorcaratto A, Nicolo G, Kaczmarek J, Querze G, Zardi L (1994) The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer 59:612–618PubMedCrossRef

19.

20.

Manabe R, Oh-e N, Sekiguchi K (1999) Alternatively spliced EDA segment regulates fibronectin-dependent cell cycle progression and mitogenic signal transduction. J Biol Chem 274:5919–5924PubMedCrossRef

21.

Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142:873–881PubMedCrossRef

22.

Manabe R, Ohe N, Maeda T, Fukuda T, Sekiguchi K (1997) Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J Cell Biol 139:295–307PubMedCrossRef

23.

Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11–25PubMedCrossRef

24.

Pierschbacher MD, Ruoslahti E (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30–33PubMedCrossRef

25.

Goke M, Zuk A, Podolsky DK (1996) Regulation and function of extracellular matrix intestinal epithelial restitution in vitro. Am J Physiol 271:G729–G740PubMed

26.

Johansson S, Svineng G, Wennerberg K, Armulik A, Lohikangas L (1997) Fibronectin-integrin interactions. Front Biosci 2:d126–d146PubMed

27.

Leeb SN, Vogl D, Gunckel M, Kiessling S, Falk W, Goke M, Scholmerich J, Gelbmann CM, Rogler G (2003) Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase. Gastroenterology 125:1341–1354PubMedCrossRef

28.

Meier JH, Leeb SN, Falk W, Scholmerich J, Rogler G (2003) The migratory potential of Crohn’s disease myofibroblasts differs significantly between inflamed mucosa, strictures, and fistulae. Gastroenterology 124(Suppl. 1):A–329

29.

Leeb SN, Vogl D, Grossmann J, Falk W, Scholmerich J, Rogler G, Gelbmann CM (2004) Autocrine fibronectin-induced migration of human colonic fibroblasts. Am J Gastroenterol 99:335–340PubMedCrossRef

30.

Brenmoehl J, Lang M, Hausmann M, Leeb SN, Falk W, Scholmerich J, Goke M, Rogler G (2006) Evidence for a differential expression of fibronectin splice forms ED-A and ED-B in Crohn’s disease (CD) mucosa. Int J Colorectal Dis 22:611–623PubMedCrossRef

31.

Leeb SN, Vogl D, Falk W, Scholmerich J, Rogler G, Gelbmann CM (2002) Regulation of migration of human colonic myofibroblasts. Growth Factors 20:81–91PubMedCrossRef

32.

Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S (1997) Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn’s disease. Am J Pathol 150:823–832PubMed

33.

Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash GS (1991) Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 101:1020–1030PubMed

34.

Schreiber S (1999) Activation of nuclear factor kappaB as a target for anti-inflammatory therapy. Gut 44:309–310PubMed

35.

Nielsen OH, Koppen T, Rudiger N, Horn T, Eriksen J, Kirman I (1996) Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 41:1786–1793PubMedCrossRef

36.

Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S (1998) Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 42:470–476PubMedCrossRef

37.

Braegger CP, MacDonald TT (1994) Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy 72:135–141PubMed

38.

Elsasser-Beile U, von Kleist S, Gerlach S, Gallati H, Monting JS (1994) Cytokine production in whole blood cell cultures of patients with Crohn’s disease and ulcerative colitis. J Clin Lab Anal 8:447–451PubMedCrossRef

39.

Funakoshi K, Sugimura K, Sasakawa T, Bannai H, Anezaki K, Ishizuka K, Yoshida K, Narisawa R, Asakura H (1995) Study of cytokines in ulcerative colitis. J Gastroenterol 30(Suppl 8):61–63PubMed

40.

Monteleone G, MacDonald TT (2000) Manipulation of cytokines in the management of patients with inflammatory bowel disease. Ann Med 32:552–560PubMedCrossRef

41.

Murata Y, Ishiguro J, Itoh J, Munakata A, Yoshida Y (1995) The role of inflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol 30(Suppl 8):56–60PubMed

42.

Stallmach A, Giese T, Schmidt C, Ludwig B, Mueller-Molaian I, Meuer SC (2004) Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn’s disease. Int J Colorectal Dis 19:308–315PubMedCrossRef

43.

Camoglio L, Te Velde AA, Tigges AJ, Das PK, Van Deventer SJ (1998) Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis 4:285–290PubMedCrossRef

44.

Brouty-Boye D, Zetter BR (1980) Inhibition of cell motility by interferon. Science 208:516–518PubMedCrossRef

45.

Adelmann-Grill BC, Hein R, Wach F, Krieg T (1987) Inhibition of fibroblast chemotaxis by recombinant human interferon gamma and interferon alpha. J Cell Physiol 130:270–275PubMedCrossRef

46.

Postlethwaite AE, Seyer JM (1990) Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31–68 peptide. J Exp Med 172:1749–1756PubMedCrossRef

47.

Goetze S, Xi XP, Kawano Y, Kawano H, Fleck E, Hsueh WA, Law RE (1999) TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension 33:183–189PubMed

48.

Simmons JG, Pucilowska JB, Keku TO, Lund PK (2002) IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol 283:G809–G818PubMed

49.

Vaughan MB, Howard EW, Tomasek JJ (2000) Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 257:180–189PubMedCrossRef

50.

Mulsow JJ, Watson RW, Fitzpatrick JM, O’Connell PR (2005) Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling. Ann Surg 242:880–887, discussionPubMedCrossRef

51.

Wells RG (2000) Fibrogenesis: V. TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol 279:G845–G850PubMed

52.

Branton MH, Kopp JB (1999) TGF-beta and fibrosis. Microbes Infect 1:1349–1365PubMedCrossRef

53.

Feagan BG, Enns R, Fedorak RN, Panaccione R, Pare P, Steinhart AH, Wild G (2001) Infliximab for the treatment of Crohn’s disease: efficacy, safety and pharmacoeconomics. Can J Clin Pharmacol 8:188–198PubMed

54.

Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8:244–250PubMedCrossRef

55.

Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, Van Deventer SJ (2004) Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 350:876–885PubMedCrossRef

56.

Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, Van Deventer SJ (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340:1398–1405PubMedCrossRef

57.

Title: Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF)
Authors: Julia Brenmoehl
Werner Falk
Michael Göke
Jürgen Schölmerich
Gerhard Rogler
Publication date: 01-10-2008
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 10/2008
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-008-0523-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF)

Abstract

Background

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 10/2008

Single port access laparoscopic right hemicolectomy

Stapled trans-anal rectal resection (STARR) by a new dedicated device for the surgical treatment of obstructed defaecation syndrome caused by rectal intussusception and rectocele: early results of a multicenter prospective study

Perioperative adjuvant therapy with infliximab in complicated anal crohn’s disease

Stent placement for benign colonic stenosis: case report, review of the literature, and animal pilot data

Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment

Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases